Investor

Presentation

2025 H1 Report

Registrations Globally8400+

Staffs Globally5000+

Operational Countries100+

Independent Patents350+

Rainbow Global

Manufacturing BaseSpain

Overseas Subsidiaries110+

Manufacturing BaseArgentina

U.S. Houston, ChampaignManufacturing Base

Weifang Process Development CenterWeifang, Jinan R&D CentersGlobal Operation CenterJinan

Weifang, Qingdao, NingxiaManufacturing Bases

Global OperationCenter

Manufacturing

Base

Subsidiary /

Office

R&D Centers

Crop Protection Industry Status

* HS: Harmonized System

As high-cost inventories are gradually depleted,irrational low-price dumping of various products hassignificantly decreased. Supported by decliningsupply-side costs, gross margins in most with terminalmarkets have now increased to reasonable levels.

The operating performance of mostcompanies in the industry has shownrecovery or significant improvementYOY compared to 2024, with leadingenterprises demonstrating clearersigns of rebound from the cyclicaltrough.Overseasinventorylevelsremainedlow,whileglobaldemandforcropprotectionproductsreturnedtonormalwithsustainedstrength.Bulkagriculturalpricesremainatmedianhistoricallevels,withactivefarmerapplicationwillingnessandstablecultivationacreage,demonstratingsustainedinelasticdemandforcropprotectionproducts.ChinaCustomsdatashows17.07%YoYgrowthinHS3808exportvolumeand13.72%invalueforJan-Jun

2025,indicatingstrongglobalmarketdemand.

Debt default risks continue toescalate in key crop protectionmarkets such as Brazil andArgentina, adversely impactingbusiness operation stability inthese regional markets.

27.48

17.21

28.62

27.24

30.86

30.86

22.33

18.90

24.86

22.99

25.47

24.06

25.18

24.48

18.77

24.92

22.54

26.93

14.39

11.95

17.43

14.43

15.41

17.10

22.21

21.83

23.11

19.57

19.25

19.75

18.51

10.50

15.96

12.83

18.75

20.70

21.33

17.99

14.67

13.82

14.42

13.21

10.00 15.00 20.00 25.00 30.00 35.00

123456789101112

Industry Overview

2025202420232022

?H1 2025: Total export volume increased by 17.07% YoY.?Q2 2025: Total export volume increased by 22.67% YoY.

Export Volume Trends of Products Under China HS Code 380810k Tons

10k Tons

* HS: Harmonized System

Export Value Trends of Products Under China HS Code 3808

123456789101112

2025202420232022

7.88

4.59

7.69

7.65

8.80

8.79

6.65

5.42

6.94

6.32

7.44

7.15

7.64

7.71

6.12

7.28

6.66

7.71

6.58

4.94

7.26

5.60

5.53

5.41

6.75

6.65

7.27

6.41

5.90

6.07

11.05

6.31

9.02

7.50

10.47

11.07

11.35

9.86

7.79

6.81

6.58

5.82

2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00

Hundred Million USD

* HS: Harmonized System

?H1 2025: Total export value increases by 13.72% YoY.?Q2 2025: Total export value increased by 20.69% YoY.

Industry Overview

123456789101112

Export Unit Price Trends of Products Under China HS Code 3808

USD/Kg

USD/Kg

Industry Overview

2025202420232022

* HS: Harmonized System

?H1 2025: Monthly average export unit price decreased from $ 2.87/kg in January to$2.85/kg in June.

H1 2025 Operational Review

?IT Initiatives: By the end of 2029, the company aims

to achieve 100% global coveragefor SAP, CRM, BI,comprehensive budgeting systems, and globalcollaboration tools.?Process Optimization: By 2029, the company will fullyimplementfour core business processes (DSTE, MTC,

CTP, PTD)andfive supporting processesto enhanceoperational efficiency.

Global ManagementSystem Based on NineCore Processes

?Two Shortcomings: The 2025-2029 mid-term strategyhighlights two critical capability gaps at the marketfrontline: commercialization of key differentiatedproducts and brand business development.?Strategic Realignment: Frontline teams have

swiftlyaligned upwardwith these priorities, driving keyinitiatives while dynamically aligning with corporatestrategic objectives, demonstrating strong executioncapabilities.

Company IdentifiesKey Capability Gaps inMarket Frontlines

?ProactiveRealignmentofPerformanceMetricsAligningwith2025-2029mid-termstrategy,wepromptlyrecalibratedperformancemetrics,significantlyincreasingweightingsforoperationalqualityindicators(grossmargin,NPAT,overdueAR,andlong-terminventory)whiledrasticallyreducingsalesrevenue'sweighting.

?TalentStrategy&CorporateCultureConfidenceWemaintainourestablishedexpatriatepolicyfor

frontlineChineseteamsandenforcestrictvalue-basedselectionforallkeyroles(Chineseexpatriates/localmanagers).Post-replacementofunderperformingModelCsubsidiarymanagers(2024-2025),performanceimprovedmarkedly.Our"Commissar+Commander"model(veteranChineseexpats+localleaders)nowgovernsmostModelCunits,demonstratingoperationalculturalconfidence.?Thecompany'sModelCoverseassubsidiarieshaveshownsteadilyimprovingperformanceoverthepastfiveyears,nowdeliveringstrongandsustainableresultsastheglobaloperationssystemmatures.?VisionaryPortfolioStrategy&SustainedGlobalRegistrationInvestmentIdentifyingsuitableAI,ensurethesuccessfulimplementationthroughstrongandadvancedtechnologywithproperways,sothatwecanhavemoreglobalpowerfulsynthesisAItosupportourmarketdevelopment,improvingourcompetitivityandprofitability.H12025delivered600+newapprovals,reaching8,400+totalglobal

registrationsasofJune30,2025.

H1 2025 Operational Review

Enhance Quality,Boost Efficiency:

Ongoing Expansion

and Optimization

of the GlobalMarketing Network

H1 2025 Operational Review

Four StrategicGrowth PillarsOperationReview

Increased To C BusinessTOCrevenuerosefrom37.52%inH12024to40.14%inH12025,withgrossmarginimprovingfrom29.21%to30.21%

Increased EU & NA Business

EU&NorthAmericanoperationsincreasedfrom11.42%inH12024to14.08%inH12025.

Increased Insecticide & FungicideBusinessInsecticide&fungiciderevenueincreased

from24.15%inH12024to26.59%inH12025.

Rainbow Bio BusinessAcceleration

RainbowBiohaslaunchedinmultiplenewcountriesacrossAfrica,Asia,andtheAmericaswhiledeepeningpenetrationinexistingmarkets.

*EU: European Union*NA: North American

CurrencyRMB

H1 2025H1 2024% Note

Sales Revenue

6,530,775,333.21 5,681,756,659.38 14.94%

Stable growth across all businesssegments.

Gross Margin%

21.42% 20.23% 1.19%

YoY gross margin rate improvement forboth Model A/B and Model C businesses.

EBITDA

815,410,474.59700,234,948.6516.45%EBITDA Profit%

12.49%12.32%0.17%

Net Profit Attributable to

the Owner of Parent

555,603,360.29 181,794,252.02 205.62%

?

Revenue growth with gross margin rate

enhancement?

Increased financial expenses & hedging

gainsNet Operating Cash Flow893,182,242.16-138,751,214.78743.73%

Improved payment collection

Financial HighlightsH1 2025 Financial Performance Analysis (YoY)

CurrencyRMB

H1 2025H1 2024% Note

Selling & Distribution

Expenses

340,844,593.06 267,719,127.15 27.31%

Higher sales expenses mainly stemmedfrom increased overseas payroll, exportcredit insurance and exhibition expenses.

General & Administrative

Expenses

253,142,837.69 212,412,218.74 19.18%

Higher administrative expenses weremainly due to increased overseas payroll.

R&D Expenses83,428,312.99 71,842,120.14 16.13%

Primarily due to increased R&D investment.

Financial HighlightsH1 2025 Financial Performance Analysis (YoY)

CurrencyRMB

Q2 2025Q2 2024% Note

Sales Revenue3,844,489,498.82 2,988,565,060.43 28.64%

Stable growth across all businesssegments.

Gross Margin%

22.92%20.34%2.58%

YoY gross margin rate improvement forboth Model A/B and Model C businesses.

EBITDA

537,959,601.08382,342,060.1140.70%EBITDA Profit%

13.99%12.79%1.20%

Net Profit Attributable to

the Owner of Parent

298,860,730.79 28,950,900.77 932.3%

?

Revenue growth with gross margin rate

enhancement?

Increased financial expenses & hedging

gainsNet Operating Cash Flow959,942,509.21159,232,288.32

502.86%

Improved payment collection

Financial HighlightsQ2 2025 Financial Performance Analysis (YoY)

CurrencyRMB

Q2 2025Q2 2024% Note

Selling & Distribution

Expenses

179,977,396.99 131,707,000.96 36.65%

Higher sales expenses mainly stemmedfrom increased overseas payroll, exportcredit insurance and professional servicefees.

General & Administrative

Expenses

126,886,423.26 117,179,271.77 8.28%

Higher administrative expenses weremainly due to increased professionalservice fees and IT expenses.

R&D Expenses41,949,748.20 35,755,229.05 17.32%

Primarily due to increased R&D investment.

Financial HighlightsQ2 2025 Financial Performance Analysis (YoY)

Financial HighlightsH1 2025 New Global Registration Status by Geographic Segment

Brazil

2.55%

LatinAmerica

29.62%

NorthAmerica

0.64%

Europe

17.83%

MiddleEast/Africa

16.40%

Asia (Chinainclusive)

31.21%

Oceania

1.75%

H1 2025 NewApprovals:

600+

Total Global Registration Status by Geographic Segment as of June 2025

Brazil

1.98%

LatinAmerica

40.43%

NorthAmerica

0.32%

Europe

7.33%

MiddleEast/Africa

17.66%

Asia (Chinainclusive)

25.08%

Oceania

7.20%

Total Approvals8400+

Financial Highlights

H1 2025 Revenue Status by Geographic Segment

H1 2025 Revenue

6.531billionRMB

Financial Highlights

Oceania

5.37%

Asia (China

inclusive)

16.40%

Europe

7.60%

Europe

7.60%

NorthAmerica

8.76%

NorthAmerica

8.76%

Latin

America

25.55%

Latin

America

25.55%

Brazil

25.56%

Revenue Share by Segment (YoY)

Revenue by Segment (H1)Quarterly Revenue by Segment

Q2 2024

Mode A +Mode B

62.16%

Mode C

37.84%

H1 2024

Mode A +Mode B

62.48%

Mode C

37.52%

H1 2025

Mode A +Mode B

59.86%

Mode C

40.14%

Q2 2025

Mode A +Mode B

58.65%

Mode C

41.35%

Q1 2025

Mode A +Mode B

61.61%

Mode C

38.39%

Financial Highlights

Gross Margin Rate by Segment (H1)Quarterly Gross Margin Rate by Segment

Gross Margin Rate Comparison by Segment

Financial Highlights

Q2 2025

Revenue by Product Category

Revenue by Product Category (H1)Quarterly Revenue by Product Category

Q2 2024

Herbicide

75.15%

Insecticide

13.89%

Fungicide

9.93%

Other 1.03%

H1 2025

Q1 2025

Herbicide

71.53%

Insecticide

16.50%

Fungicide

10.78%

Other 1.19%

H1 2024

Herbicide

74.73%

Insecticide

13.94%

Fungicide

10.21%

Other 1.12%

Financial Highlights

Gross Margin Rate Comparison by Product Category

Gross Margin Rate by Product Category (H1)Quarterly Gross Margin Rate by Product Category

Financial Highlights

The crop protection industry remains at the cyclical bottom but shows initialrecovery signs: Competitive leaders with technological, channel and brandadvantages demonstrate clear recovery momentum, continuouslystrengthening their market position.

2025 Global Crop Protection Industry Outlook

Crop AIs prices softening, and remain range-bound at cyclical lows.

Procurement Shifts Challenge Supply Chains: Channels and end-users nowfavor minimal inventories, delayed purchases, and just-in-time buying,straining crop protection supply networks.

Products at historical price lows remain prone to sudden volatilityfrom disruptive events, necessitating true demand-driven systemswith rapid, flexible operations

2025 Global Crop Protection Industry Outlook

Growers increasingly favor more cost-effective generic cropprotection products to improve profitability, accelerating their marketshare growth.

Market demand remains moderately elevated, with terminal marketprices progressively normalizing to rational levels.

Rising trade protectionism disrupts import

tariffs, market access, exchange rates, andcommodity prices, increasing operationaluncertainties.

Terminal market prices and gross marginsare gradually normalizing, with subsidiariessustaining gross margin rate expansion.

Expanding To C revenue share and high-value global registrations will drivesustained operating gross margin rateimprovement.

Process-and IT-enabled globalmanagement systems drive continuousimprovement in global operational qualityand capabilities.

2025 Targets: both revenue andshareholder net profit to grow YoY

2025 Business Outlook

"Enhance Quality, Boost Efficiency"

Mid-Term Strategic Plan (2025-2029)-Annual Review Update

4 Strategic Growth Pillars

Increased To C Business

Increased EU & NA Business

Increased Insecticide & Fungicide Business

Rainbow Bio Business Acceleration

Mid-Term Strategic Plan (2025-2029)-Annual Review Update

*EU: European Union*NA: North American

Buildinguptheglobalmanagementsystem,toensurethecompanyunderhealthyandsafeoperation.Identifyingimportantproductsprospectively,bethefirstgenericcompanytocommercializeincoremarketssuccessfully.Identifying suitable AI, ensure the successful implementation through strong and advanced technology with proper ways, so that we canhave more global powerful synthesis AI to support our market development, improving our competitivity and profitability.Improvingtheformulationcapabilitiestobehighcost-effectiveandefficient,tosupportproductregistrationquickdeliveryandsuccessfulcommercialization.

Continueexpandinganddevelopingglobalbusiness,strengthenbrandbuilding,toensurebusinessgrowinabalanced andhealthyway.Thoroughlyunderstandtheinformationfromfactoriestofarms,makingaccurateandquickdecisions,developingmore nicheAIsandbuildingstrategyalignspartnerswithdifferentways,toensureglobalsupplychaintobesafeandcompetitive.Continuouslyoptimizingorders’wholeprocessingsystem,toensurethehigh-quality,cost-effective,andfastdeliveryonschedule.

1.2.3.

4.5.6.

7.

7 Critical Tasks

Mid-Term Strategic Plan (2025-2029)-Annual Review Update

Global Management Capability

Differentiated Product Commercialization Capability

Brand Business Development Capability

High-Compatibility & Synergy-Enhanced Formulation Technology

Agile & Precise Global Supply Chain

5 Key Management CapabilitiesMid-Term Strategic Plan (2025-2029)-Annual Review Update

To be a Global Leading Crop

Protection Company